HRMY - Harmony Biosciences Holdings, Inc.

Across the last three months, Harmony Biosciences Holdings, Inc.'s insiders have reduced their positions by a net 72,406 shares worth roughly $3.1M.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Sandip Kapadia	24.5K	$907.8K	-
Other	Kumar Budur	13.1K	$485.5K	-
CEO	Jeffrey M. Dayno	7.3K	$271.9K	-
Other	Adam H. Zaeske	4.3K	$160.2K	-
Other	Andrew Serafin	1.5K	$54.6K	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 3, 2024	Jeffrey Dierks62	Chief Commercial Officer	Sell	36,357	$35.06	$1,274,546.50	-100%	+0.2%	-21.5%
Oct 1, 2024	Jeffrey Dierks62	Chief Commercial Officer	Sale+OE	400	$40.19	$16,076.92	-	-13.2%	-31.4%
Sep 30, 2024	Jeffrey Dierks62	Chief Commercial Officer	Sale+OE	35,846	$40.03	$1,434,951.23	-	-14.8%	-31.1%
Sep 27, 2024	Jeffrey Dierks62	Chief Commercial Officer	Sale+OE	200	$40.05	$8,009.00	-	-11.3%	-29.7%
Mar 15, 2024	Jeffrey Dierks62	Chief Commercial Officer	Sale+OE	11,979	$32.00	$383,328.00	-	-6.9%	+2.3%
Mar 8, 2024	Jeffrey Dierks62	Chief Commercial Officer	Sale+OE	194	$32.00	$6,208.00	-	-1.8%	+8.3%
Dec 14, 2022	Jack Nielsen76	Director	Sell	2,834	$59.96	$169,926.64	-0.1%	-29.2%	-42.4%
Dec 14, 2022	Andreas Wicki71	Director	Sell	28,841	$60.31	$1,739,342.36	-1.3%	-29.2%	-42.4%
Dec 9, 2022	Jack Nielsen76	Director	Sell	110,751	$60.16	$6,662,698.13	-4.1%	-27.6%	-47.5%
Dec 5, 2022	Andreas Wicki71	Director	Sell	77,853	$61.23	$4,766,939.19	-3.5%	-28.9%	-46.8%